Syrris to launch Titan continuous processing scale-up system at InformEX
9 May 2017 | By Syrris
Syrris is launching its revolutionary Titan system at InformEX in Philadelphia, USA, from the 16th to the 18th of October...
List view / Grid view
News
Ireland reiterates bid to host the European Medicines Agency post-Brexit
9 May 2017 | By Niamh Marriott, Junior Editor
Ireland has stepped up its bid to host the European Medicines Agency (EMA) with the official announcement being delivered and reiterated bySimon Harris...
Inducing protein aggregation by extensional flow makes drugs less effective
9 May 2017 | By University of Leeds
Data from a new device demonstrates maximal levels of extensional flow which manufacturers could use for different processes, without damaging proteins...
bioLytical Partners with Pasante on UK distribution of INSTI HIV self test
8 May 2017 | By Niamh Marriott, Junior Editor
bioLytical Laboratories has developed the INSTI HIV Self Test following research revealing that over 103,000 people are living with HIV in the UK...
Customised vibrating separators for the pharmaceutical industry
Customised vibrating separator increases productivity and product quality for pharmaceutical filler manufacturer.
Braeburn achieves endpoints in implant study to treat Schizophrenia
8 May 2017 | By Niamh Marriott, Junior Editor
Braeburn Pharmaceuticals’ 6-month study of the safety, tolerability and pharmacokinetics of transferring patients diagnosed with schizophrenia...
Aptar Pharma & Kali Care to develop medication monitoring tech for trials
8 May 2017 | By Niamh Marriott, Junior Editor
Aptar Pharma’s dispensing technologies combined with Kali Care’s smart sensors, data analytics and cloud services will make clinical trials more efficient.
Roche receives FDA approval for bladder cancer biomarker assay
5 May 2017 | By Niamh Marriott, Junior Editor
The FDA has approved Roche’s biomarker assay as a complementary diagnostic to provide PD-L1 status for patients with urothelial carcinoma...
Braeburn and Camurus’ Phase III opioid use disorder trial a success
5 May 2017 | By Niamh Marriott, Junior Editor
Braeburn Pharmaceuticals and Camurus announced positive results from Phase 3 trial supporting the safety and efficacy of CAM2038 in opioid use disorder...
AstraZeneca’s new formulation tablets receive positive CHMP opinion
5 May 2017 | By
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the adoption of AstraZeneca’s Brilique (ticagrelor) 90mg orodispersible tablets (ODT) as a new method of treatment administration. This opinion is the first step towards the adoption of a new…
Cherwell Laboratories to highlight cleanroom microbiology solutions at The Clinical Pharmacy Congress
5 May 2017 | By Cherwell Laboratories
Cherwell Laboratories will be exhibiting at the Clinical Pharmacy Congress...
Innovative drug delivery platform relies on Telos® Reagent Chips
4 May 2017 | By Dolomite Microfluidics
Telos® 2 Reagent Chips from Dolomite Microfluidics have helped San Francisco-based ProLynx LLC to develop a novel drug delivery platform...
First ever evidence of treatment-induced reduction in HIV reservoirs
4 May 2017 | By Niamh Marriott, Junior Editor
Abivax’s lead therapeutic candidate ABX464 demonstrated the first reduction in HIV reservoirs ever observed in chronically infected HIV patients...
FDA approves Roche’s high-volume immunoassay
4 May 2017 | By Niamh Marriott, Junior Editor
Roche’s new, dedicated high-volume testing immunoassay solution for the cobas 8000 modular analyser series, the cobas e 801 module, has received 510(k) clearance from the US Food and Drug Administration (FDA). As core laboratories continue to evolve to meet the growing workload demands in an increasingly challenging environment, the cobas…
FDA approves new combination treatment for acute myeloid leukaemia
4 May 2017 | By Niamh Marriott, Junior Editor
The drug is approved for use in combination with LeukoStrat CDx FLT3 Mutation Assay, which is used to detect the FLT3 mutation in patients with AML...
